Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas: Correlation with cydin D1 (PRAD1/CCND1) mRNA levels and proliferative activity

American Journal of Pathology

Volumn 148, Issue 5, 1996, Pages 1591-1600

  Jares, Pedro ^a,b   Campo, Elías ^a,b,e   Pinyol, Magda ^a   Bosch, Francesc ^a   Miquel, Rosa ^a   Fernandez, Pedro Luis ^a   Sanchez Beato, Margarita ^c   Soler, Francesc ^d   Perez Losada, Alejandra ^d   Nayach, Iracema ^a   Mallofré, Carme ^a   Piris, Miguel Angel ^c   Montserrat, Emilio ^a   Cardesa, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Universitat de Lleida Facultat de Medicina Sabadell   (Spain)

^c HOSPITAL VIRGEN DE LA SALUD   (Spain)

^d Hospital Central L'Alianca   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; GENE PRODUCT; MESSENGER RNA; MONOCLONAL ANTIBODY KI 67; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CELL CYCLE; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; GENE EXPRESSION; GENE REARRANGEMENT; GENE STRUCTURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; PATHOGENESIS; PLOIDY; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL CYCLE; CELL DIVISION; CYCLIN D1; CYCLINS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RETINOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; RNA, MESSENGER;

EID: 0029979182     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Weisenburger DD, Sanger WG, Armitage JO, Purtilo DT. Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings Blood 1987, 69 1617-1621
2. Vandenberghe E, de Wolf-Peters C, van den Oord J, Wlodarska I, Delabie J, Stul M, Thomas J, Michaux JL, Mecucci C, Cassiman JJ, van den Berghe H: Translocation (11;14). a cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage J Pathol 1991, 163 13-18
3. Williams ME, Westermann CD, Swerdlow SH. Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. Blood 1990, 76:1387-1391
4. Medeiros LJ, Van Krieken JH, Jaffe ES, Raffeld M: Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation Blood 1990, 76:2086-2090
5. Raffeld M, Jaffe ES. bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 1991, 78:259-263
6. Withers DA, Harvey RC, Faust JB, Malynk O, Carey K, Meeker TC: Characterization of a candidate bcl-1 gene. Mol Cell Biol 1991, 11.4846-4853
7. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A: A novel cyclin encoded by BCL1-linked candidate oncogene. Nature 1991, 350:512-515
8. Rosenberg CL, Wong E, Petty EM, Balf AE, Tsujimoto Y, Harris NL, Arnold A. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 1991, 88 9638-9642
9. Rimokh R, Berger F, Delsol G, Charrin C, Bertheas MF, French M, Garoscio O, Felman P, Coiffier B, Bryon PA, Rochet M, Genthilhomme O, Germain D, Magaud JP: Rearrangement and overexpression of the BCL-1/ PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 1993, 81: 3063-3067
10. Oka K, Ohno T, Kita K, Yamaguchi M, Takakura N, Nishi K, Miwa H, Shirakawa S. PRAD-1 gene overexpression in mantle cell lymphoma but not in other low grade B-cell lymphomas, including extranodal lymphoma. Br J Haematol 1994, 86:786-791
11. Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris MA, Villamor N, Tassies D, Jaffe ES, Montserrat E, Rozman C, Cardesa A. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders a highly specific marker of mantle cell lymphoma. Blood 1994, 84:2726-2732
12. Yang W-I, Zukerberg LR, Motokura T, Arnold A, Harris NL. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia Am J Pathol 1994, 145:86-96
13. Jiang W, Kahn SM, Zhou P, Zhang Y, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB: Overexpression of cyclin D1 in rat fibrobtasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993, 8:3447-3457
14. Quelle DE, Ashmun RA, Shurtleff SA, Kato J, Bar-Sagi D, Roussel M, Sherr CJ. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993, 7:1559-1571
15. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993, 7.812-821
16. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J Cyclin D1 protein expression, and function in human breast cancer. Int J Cancer 1994, 57.353-361
17. Tan SW, Theodoras AM, Shay JW, Draetta GF, Pagano M. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with cdk4 is required for cyclin D1 function in G1 progression Oncogene 1994, 9.2663-2674
18. Hinds PH, Dowdy S, Eaton EN Arnold A, Weinberg RA: Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 1994, 91:709-713
19. Lovec H, Sewing A, Lucibello FC, Muller R, Moray T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant traansformation. Oncogene 1994, 9 323-326
20. Lovec H, Grzeschiczek A, Kowalski M-B, Moroy T: Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphomas in transgenic mice EMBO J 1994, 13:3487-3495
21. Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ: Identification and properties of an atypical catalytic subunit (p34 psk-J3/cdk4) for mammalian D type G1 cyclins. Cell 1992, 71.323-334
22. Ewen ME, Sluss HK, Sherr CJ, Matshushime H, Kato J, Livingston DM Functional interactions of the retinoblastoma protein with mammalian D-type cyclins Cell 1993, 73.487-497
23. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato J-Y: D-Type cyclin-dependent kinase activity in mammalian cells Mol Cell Biol 1994, 14. 2066-2076
24. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA: Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993, 73:499-511
25. Hinds PH, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 1992, 70.993-1006
26. Lukas J, Muller H, Bartkov AJ, Spitkovsky D, Kjerulff AA, Jansen-Durr P, Strauss M, Bartek J: DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 1994, 125.625-638
27. Muller H, Lukas J, Schneider A Warthoe P, Bartek J, Eilers M, Strauss M Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 1994, 91 2945-2949
28. Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES: Lymphocytic lymphoma of intermediate differentiation, morphologic and immunophenotypic spectrum and clinical correlations Am J Surg Pathol 1990, 14:752-763
29. Zucca E, Stein H, Coiffier B: European lymphoma task force (ELTF): report of the workshop on mantle cell lymphoma (MCL) Ann Oncol 1994, 5:507-511
30. Ginsberg AM, Raffeld M, Cossman J: Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood 1991, 77:833-840
31. Martinez JC, Piris MA, Sanchez-Beato M, Villuendas R, Orradre JL, Algara P, Sanchez-Verde L, Martinez P: Retinoblastoma (Rb) gene product expression in lymphomas correlation with Ki67 growth fraction. J Pathol 1993, 169 405-412
32. Weide R, Tiemann M, Pfluger KH, Koppler H, Parvizl B, Wacker HH, Kreipe HH, Havemann K, Parwaresch MR: Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas. Leukemia 1994, 8:97-101
33. Jiang W, Zhang Y-J, Kahn SM, Hollstein MC, Santella RM, Lu S-H, Harris CC, Montesano R, Weinstein IB Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Nat Acad Sci USA 1993, 90 9026-9030
34. Schauer IE, Siriwardana S, Langan TA, Sclafani RA. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer Proc Natl Acad Sci USA 1994, 91.7827-7831
35. Banks PM, Chan J, Clearly ML, Delsol G, de Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Mason D, Pileri S, Ralfkiaer E, Stein H, Warnke RA: Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992, 16:637-640
36. Pinyol M, Campo E, Nadal A, Terol MJ, Jares P, Nayach I, Fernandez PL, Piris MA, Montserrat E, Cardesa A: Detection of the bcl-1 rearrangement at the major translocation cluster (MTC) in frozen and paraffin embedded tissues of mantle cell lymphomas by polymerase chain reaction. Am J Clin Pathol 1996 (in press)
37. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave processed formalin-fixed paraffin sections J Pathol 1992, 168 357-363
38. Harden DG, Klinger HP (Eds): ISCN An International System for Human Cytogenetic Nomenclature. Basel, Karger, 1985
39. Glisin V, Crkvenjakov R, Byus C. Ribonucleic acid isolated by cesium chloride centrifugation Biochemistry 1974, 13:2633-2637
40. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A PRAD-1/ cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas Cancer Res 1994, 54 4813-4817
41. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986, 323:643-646
42. Medley DW, Fnedlander HL, Taylor JW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow-cytometry. J Histochem Cytochem 1983, 31:1333-1335
43. Shanicey TV, Rabinovitch PS, Baqwell B, Baver KD, Duque RE, Hedley DW, Mayall BH, Wheeless L: Guidelines for implementation of clinical DNA cytometry. Cytometry 1993, 14:472-477
44. Hiddemann W, Schumann J, Andreef MBB, Herman CJ, Leif RC, Magall BH, Hurphy RF, Sandberg AA Convention on nomenclature for DNA cytometry Cytometry 1986, 5:445-446
45. Xu H-J, Hu S-X, Benedict WF: Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level. Oncogene 1991, 6 1139-1146
46. Seto M, Yamamoto K, Iida S, Akao Y, Utsumi KR, Kubonishi I, Miyoshi I, Ohtsuki T, Yawata Y, Namba M, Motokura T, Arnold A, Takahashi T, Ueda R: Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 1992, 7:1401
47. Rimokh R, Berger F, Bastard C, Klein B, French M, Archimbaud E, Rouault JR, Lucia BS, Duret L, Vuillaume M, Coiffier B, Bryon P-A, Magaud JR. Rearrangement of CCND1 (BCL-1/PRAD1) 3′ untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. Blood 1994, 83.3689-3696
48. Lukas J, Jadayel D, Bartkova J, Nacheva E, Dyer MJS, Strauss M, Bartek J: BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. Oncogene 1994, 9:2159-2167
49. Bianchi AB, Fisher SM, Robles AI, Rinchik EM, Conti CJ Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene 1993, 8.1127-1133
50. Hernandez L, Fest T, Cazorla M, Teruya-Feldstein J Bosch F, Peinado MA, Piris MA, Montserrat E, Cardesa A, Jaffe ES, Campo E, Raffeld M: p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 1996 (in press)